Conference: AMCP Annual Meeting 2025
日期 March 31-2025 年 4 月 3 日
地点 Houston, Texas
展位： #615
Market Access & Pricing Solutions for All Phases of Drug Development
临床前
- Candidate drug selection
- Comparator in clinical trials
- Market potential assessment
- Market landscape assessment (ongoing through all phases)
Early Clinical (Phase I and II)
- Clinical trial design input
- Go/no-go decisions on continued product development
- Indication prioritization
- First price scenarios
- Pricing/reimbursement barriers
- Initial segmentation
Late Clinical (Phase III and Launch Prep)
- Payer value story and messaging
- Global pricing strategy
- Launch sequence
- Pricing, contracting and rebate strategy
- Global value/AMCP dossier
- Support material for regions/affiliates
Post-Launch (Lifecycle Management)
- Indication expansion
- Biosimilar/generic entry
- Price changes
- Ongoing contract/rebate strategy
- Entry to new markets
- New formulation or device
资源
Brochure – Market Access, Pricing & Reimbursement Services
White Paper – Evaluating the IRA’s Impact on Medicare Part B Biosimilar Reimbursement
Blog – CMS Cell and Gene Therapy (CGT) Access Model Explained
White Paper – Launching a Rare Oncology Product: Comparing Successful Strategies in the U.S. vs Europe
Meet us there
Stop by Booth #615 to speak with members of our team about the latest industry trends and upcoming projects.
